Your browser doesn't support javascript.
loading
The European Code of Cancer Practice.
Lawler, Mark; Oliver, Kathy; Gijssels, Stefan; Aapro, Matti; Abolina, Agnese; Albreht, Tit; Erdem, Sema; Geissler, Jan; Jassem, Jacek; Karjalainen, Sakari; La Vecchia, Carlo; Lievens, Yolande; Meunier, Françoise; Morrissey, Mike; Naredi, Peter; Oberst, Simon; Poortmans, Philip; Price, Richard; Sullivan, Richard; Velikova, Galina; Vrdoljak, Eduard; Wilking, Nils; Yared, Wendy; Selby, Peter.
Afiliação
  • Lawler M; Faculty of Medicine, Health and Life Sciences, Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Northern Ireland, UK.
  • Oliver K; International Brain Tumour Alliance, Tadworth, Surrey, England, UK.
  • Gijssels S; Past Co-Chair of the Patient Advisory Committee, European Cancer Organisation, Belgium.
  • Aapro M; European Cancer Organisation, Brussels, Belgium.
  • Abolina A; European Cancer Organisation, Brussels, Belgium.
  • Albreht T; National Institute of Public Health, Slovenia.
  • Erdem S; European Cancer Organisation Patient Advisory Committee (ECCO PAC), Europa Donna, Milan, Italy.
  • Geissler J; CML Advocates Network, Leukaemie-Online / LeukaNET, Germany.
  • Jassem J; Department of Oncology and Radiotherapy, Medical University of Gdansk, Poland.
  • Karjalainen S; Cancer Society of Finland and Cancer Foundation Finland, Tampere University, Finland.
  • La Vecchia C; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milano, Italy.
  • Lievens Y; Radiation Oncology Department, Ghent University Hospital & Ghent University, Ghent, Belgium.
  • Meunier F; Federation of European Academies of Medicine, Brussels, Belgium.
  • Morrissey M; European Cancer Organisation, Brussels, Belgium.
  • Naredi P; Department of Surgery, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Oberst S; Organisation of European Cancer Institutes, Brussels, Belgium.
  • Poortmans P; Department of Radiation Oncology, Iridium Netwerk and University of Antwerp, Belgium.
  • Price R; European Cancer Organisation, Brussels, Belgium.
  • Sullivan R; Institute of Cancer Policy, Conflict & Health Research Group, King's College London, King's Health Partners Comprehensive Cancer Centre, London, England, UK.
  • Velikova G; Leeds Institute of Medical Research, University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds, England, UK.
  • Vrdoljak E; Center for Oncology, Professor at the Faculty of Medicine at the University of Split, Croatia.
  • Wilking N; Department of Oncology and Radiation Physics, Skane University Hospital, Lund, Malmo, Sweden.
  • Yared W; Association of European Cancer Leagues, Brussels, Belgium.
  • Selby P; Leeds Institute of Medical Research, University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds, England, UK; University of Lincoln, England, UK. Electronic address: p.j.selby@leeds.ac.uk.
J Cancer Policy ; 28: 100282, 2021 06.
Article em En | MEDLINE | ID: mdl-35559911
ABSTRACT
There are considerable disparities between the quality of cancer care and clinical outcomes for cancer patients in different European countries, regions, hospitals and communities. These have persisted despite the introduction of many European and National Cancer Plans, an extensive portfolio of clinical guidelines and the existence of evidence based guidelines for the good practice in planning cancer healthcare systems. We describe the European Code of Cancer Practice which is a citizen and patient-centred accessible widely disseminated statement of the core requirements for good clinical cancer practice. The Code sets out 10 key overarching Rights of what a patient should expect from their healthcare system each supported by a plain language explanation. The Rights highlight the importance of equal access to affordable and optimal cancer care, good quality information about an individual patient's disease and treatment and about the quality and outcomes of the cancer service they will use. Specialised multidisciplinary cancer care teams, shared decision-making, research and innovation, a focus on quality of life, the integration of supportive and palliative care within oncology are all emphasised. There is a need for a systematic approach to supporting cancer survivors with a survivorship care plan including their rehabilitation, reintegration into society and return to work where appropriate without discrimination. The Code has been co-produced by a team of cancer patients, patient advocates and cancer professionals to bridge the gap between clinical guidelines, healthcare policies and patients' everyday experience. It is robustly evidence-based and supported by a comprehensive review of the medical literature and evidence for good clinical practice. The Code is strongly endorsed by Europe's professional and patient cancer organisations and the European Commission.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Enfermagem de Cuidados Paliativos na Terminalidade da Vida / Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Enfermagem de Cuidados Paliativos na Terminalidade da Vida / Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article